Research compounds Early human study Hormone research
Also discussed as: Growth hormone releasing peptide-6
What it is and how it works
GHRP-6 is a synthetic peptide investigated for growth-hormone release. Researchers have used it to study how growth-hormone-releasing hormone contributes to the observed response. Endocrine physiology research is different from proving a therapeutic benefit.
Source for the mechanism context →A closer look at the cited evidence
Early human study
This label describes the selected source below. It is not a complete ranking of the literature, a safety score, or an approval status.
- Study or assessment
- 1998 — GHRP-6 and endogenous GHRH in humans
- Design
- Experimental hormone-response comparison with and without a GHRH antagonist.
- Who or what was studied
- Nine healthy men aged 20 to 30.
- What was observed
- Blocking GHRH reduced most of the growth-hormone response to GHRP-6.
- Limits of interpretation
- The measured outcome was hormone response, not recovery, strength, longevity, or long-term safety.
What the evidence means
Hormonal activity does not establish an overall health benefit.
Approval and regulatory context
Not an FDA-approved wellness medicine.
Safety and uncertainty
Glucose and cortisol concerns exist.
What remains uncertain
A study that helps explain hormone signaling cannot tell a reader whether changing that signaling would improve their health. Claims about lasting outcomes need direct human evidence and a fuller safety assessment.
These summaries are introductory and are not a complete account of the literature, adverse effects, contraindications, or interactions. Absence of a listed risk does not mean absence of risk. Different compounds, formulations, and routes cannot be treated as interchangeable.
Sources behind this overview
Read the source in its full context. Source links support the overview; they do not imply endorsement of this library by the source organization.